"Vaccine Name" "Vaccine Company" "IB Date" "Risk List Available?" "BG505 SOSIP.GT1.1 gp140 Vaccine - New" "International AIDS Vaccine Initiative (IAVI)" "January 2024" "10-1074-LS(-J) - New" "Rockefeller University/Celldex Therapeutics" "December 2022" "3BNC117-LS (-J) - New" "Rockefeller University/Celldex Therapeutics" "December 2022" "3BNC117-LS (-J) - New" "Rockefeller University/Celldex Therapeutics" "January 2023" "ID93 + GLA Adjuvant Vaccine" AAHI "January 2023" "N332-GT5 gp140, Adjuvanted with SMNP" DAIDS/NIAID/NIH "June 2023" "VRC-HIVMAB0115-00-AB (VRC01.23LS)" VRC/NIAID "August 2022" MTBVAC Biofabri "January 2023" "V3G CH848 Pr-NP1, Adjuvanted and V3G CH848 mRNA-Tr2" VRC/NIAID/NIH "May 2023" "HIV-1 Adenovirus Type 4-Vectored (A549 cells) Vaccines (Ad4-Env150KN and Ad4-Env145NFL) - New" VRC/NIAID/NIH "July 2021" "16055 NFL Delta Gly4 Env Protein Trimer, Adjuvanted with 3M-052 AF + Alum - New" DAIDS/NIAID/NIH "December 2023" "INO-6160 and INO-6172" DAIDS/NIAID/NIH "January 2023" "Vesatolimod (GS-9620) - New" Gilead "April 2023" "MVA.tHIVconsv4 Vaccine" "University of Oxford" "May 2023" "MVA.tHIVconsv3 Vaccine" "University of Oxford" "May 2023" "ChAdOx1.tHIVconsv1 - New" "University of Oxford" "December 2023" ChAdOx1.HIVconsv62 "University of Oxford" "April 2023" "Selgantolimod (GS-9688)" Gilead "January 2023" "VRC-HIVVCP0l 08-00-VP (FP8vl -rTTHC)" VRC/NIAID/NIH "February 2022" "VRC-HIVRGP0106-00-VP (HIV-1 Trimer 6931 Vaccine)" VRC/NIAID/NIH "February 2022" "VRC-HIVRGP096-00-VP (HIV-1 Trimer 4571 Vaccine)" VRC/NIAID/NIH "August 2023" "GS-5423 (3BNC117-LS)" "Gilead Sciences" "January 2023" "426c.Mod.Core-C4b, Adjuvanted - New" DAIDS/NIAID/NIH "January 2024" "GS-2872 (10-1074 LS)" "Gilead Sciences" "October 2022" "AdC6-HIVgp140, AdC7-HIVgp140, CH505TF/GLA-SE Vaccines" DAIDS/NIAID/NIH "March 2021" "mRNA-1574 Trimer Vaccines" DAIDS/NIAID/NIH "July 2023" mRNA-1273 ModernaTX "December 2020" "PGDM1400LS (VRC-HIVMAB0112-00AB)" DAIDS/NIAID/NIH "December 2022" "EnvSeq-1 and EnvSeq-2" DAIDS/NIAID/NIH "October 2022" "CMV-MVA Triplex" "City of Hope National Medical Center" "May 2023" "CH505 TF chTrimer - New" DAIDS/NIAID/NIH "November 2023" "RV460 (ALF43)" DAIDS/NIAID/NIH "November 2021" "N-803 - New" "Altor BioScience (ImmunityBio)" "December 2023" "Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) - New" "Dynavax Technologies Corporation" "September 2023" "PGT121.414.LS (VRC-HIVMAB0107-00-AB)" VCMP/NIAID/NIH "June 2023" "BG505 SOSIP.664 gp140" DAIDS/NIAID/NIH "January 2023" "MPER-656 Liposomes with Aluminum Hydroxide Suspension" DAIDS/NIAID/NIH "February 2019" PGDM1400 "Beth Israel Deaconess Medical Center" "March 2021" PGT121 "Beth Israel Deaconess Medical Center" "September 2020" "RSV 6120/DeltaNS2/1030s" LID/NIAID/NIH "March 2019" 10-1074 "Rockefeller University/Mass Biologics" "September 2020" GLA-SE "Infectious Disease Research Institute (IDRI)" "May 2023" MVA-CMDR "Walter Reed Army Institute Research (WRAIR)" "November 2019" "p24CE1/2 multivalent pDNA Vaccine expressing HIV M Group p24 Gag and p55 gag pDNA with IL-12 pDNA" NCI/NIAID/NIH "November 2017" "Recombinant oligomeric gp145 C.6980 Clade C HIV Env protein" NIH/NIAID "August 2017" "RSV 276" LID/NIAID/NIH "February 2019" "RSV DeltaNS2-Delta1313-I1314L" LID/NIAID/NIH "February 2019" "VRC-HIVMAB060-00-AB (VRC01)" VRC/NIAID "August 2019" "VRC-HIVMAB075-00-AB (VRC07-523LS)" VRC/NIAID/NIH "April 2023"